Abstract:BackgroundOver-the-counter (OTC) medication package inserts are vital references for healthcare professionals to make drug recommendations and influential education materials that patients commonly refer to when self-caring. However, little is known about the quality and readability of the OTC medication package inserts in China.ObjectivesThis study aimed at evaluating the quality and readability of OTC medication package inserts.MethodsPackage inserts of OTC medication were selected based on the market share and pharmacological category. The quality of the package inserts was evaluated based on standards adapted separately from the Chinese National Medical Products Administration (NMPA) and European Medicines Agency's (EMA) Working Group. The readability was assessed using the Patient Education Materials Assessment Tool (PEMAT) in conjunction with the Chinese Readability Index Explorer (CRIE).ResultsA total of 29 OTC medication package inserts consisting of 12 Western Medicine (WM) and 17 Chinese Tradition Patent Medicine (CTPM) package inserts were included. Overall, the OTC package inserts met 92% of the NMPA standards and 54% of the EMA standards. In terms of readability assessment using PEMAT, the overall median (interquartile range) understandability score was 38% (38–45%) and for actionability score was 40% (40–55%). The overall text reading level of package inserts measured by the CRIE, after removing some medical jargon, is equivalent to the median reading level for the 12th (9.5–12th) grade reading level.ConclusionsThe quality of OTC medication package inserts was satisfactory under internal standards but poor under international standards. Some OTC pharmacological information is not provided due to lack of research, especially for CTPM. A more informative and comprehensive package insert may be needed to guide drug use decisions. OTC medication package inserts are not appropriate patient education materials in terms of readability. Additional materials may be developed to supplement package inserts for patient education for OTC medications.

Comparison of the Drug Package Inserts of Domestic and Foreign Compound Preparations Containing Narcotic Drugs

[Analysis on the Common Causes for Traditional Chinese Medicinal Injection Induced Adverse Reactions and the Preventive Countermeasures].

Research and Analysis of 180 Package Inserts of Oral Chemical Prescription Drug

Study on Narcotics and Psychotropic Substances Control( Part Ⅴ):Comparative Study on Domestic and Foreign Control System of Narcotics and Psychotropic Substances

Utilization of Narcotic Drugs in Our Hospital from 2004 to 2009

Evaluation of quality and readability of over-the-counter medication package inserts

Application and Management of Narcotics in Peking University Shougang Hospital in 2011

Current Regulatory Status and Development Trend of Drug Inserts in China

Review and Analysis on 2246 Prescriptions with Narcotic Drugs

A STUDY OF PACKAGE INSERTS: HOW ACCURATE IS THE INFORMATION PROVIDED?

Analysis of the Utilization of Narcotic Drugs for Inpatients in Our Hospital from 2012 to 2014

Comparison and Analysis on Instructions for Foreign and Domestic Aspirin Enteric-coated Tablets

Research and analysis on package insert and capacity of 36 kinds of eye drops

Analysis of the Use of Narcotics in Our Hospital from 2005 to 2007

Insufficient correctness of package inserts for psychotropic drugs in Germany

Comparison on Definitions of Counterfeit or Substandard Drugs in Several Countries throughout the World

Evaluation on administration off-label drug use at home and abroad

Analysis of Medicinal Substances and Cut Crude Drugs with Forbidding,Contraindication or Caution for Pregnancy in Chinese Pharmacopoeia(2005)

ANALYSIS OF THE LITURATURE ON PHARMACOEPIDEMIOLOGY OF DRUG ABUSE IN CHINA

Study on Narcotics and Psychotropic Substances Control( Part Ⅳ):Development and Status Quo of Nar-cotics and Psychotropic Substances Control in China

Analysis and Comparison of Foreign and Domestic Orphan Drug Registration Policies